Morgan Stanley’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34K Sell
153
-126
-45% -$1.35K ﹤0.01% 7391
2025
Q4
$2.36K Sell
279
-7,099
-96% -$78.8K ﹤0.01% 7212
2025
Q3
$85.8K Sell
7,378
-3,214
-30% -$27.3K ﹤0.01% 6222
2025
Q2
$115K Buy
10,592
+8,552
+419% +$42.5K ﹤0.01% 6083
2025
Q1
$6.18K Sell
2,040
-57,713
-97% -$354K ﹤0.01% 6934
2024
Q4
$491K Sell
59,753
-700
-1% -$6.33K ﹤0.01% 5423
2024
Q3
$406K Sell
60,453
-158,441
-72% -$873K ﹤0.01% 5496
2024
Q2
$987K Buy
218,894
+53,913
+33% +$110K ﹤0.01% 4967
2024
Q1
$219K Buy
+164,981
New +$245K ﹤0.01% 5703

Other funds holding CORZW

Morgan Stanley's CORZW Position: Q1 2026 in Review

Morgan Stanley reduced its Core Scientific Inc Tranche 1 Warrants (CORZW) stake by 45% in Q1 2026, selling an estimated $1.35K and leaving 153 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Morgan Stanley first reported a position in CORZW in Q1 2024 and has held it in 9 quarters since. The position peaked at $987K in Q2 2024. 63 funds tracked by Wall St. Rank hold CORZW as of Q1 2026.

  • Morgan Stanley held 153 shares of Core Scientific Inc Tranche 1 Warrants worth $1.34K as of Q1 2026.
  • Morgan Stanley sold 126 Core Scientific Inc Tranche 1 Warrants shares in Q1 2026, an estimated $1.35K.
  • Core Scientific Inc Tranche 1 Warrants made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7391 holding.
  • Morgan Stanley first reported a position in Core Scientific Inc Tranche 1 Warrants in Q1 2024 and has held it in 9 quarters since.
  • Morgan Stanley's Core Scientific Inc Tranche 1 Warrants position peaked at $987K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.